Switzerland signs an agreement with Pfizer to supply a total of 14 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 and 2023, which also includes an option to supply an additional 7 million vaccine doses in subsequent years.
Switzerland signs an agreement with Pfizer to supply total of 14 million more doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 and 2023, which including a option of 7 million vaccine doses each year after that.
Switzerland signs an agreement with Pfizer to supply atotal of 14 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 and 2023, which alsoincludes an option to supplyanadditional7 million vaccine doses insubsequent years.